Evaxion A/S - Sponsored ADR (EVAX) vs NextCure, Inc. (NXTC)
Evaxion A/S - Sponsored ADR and NextCure, Inc. are both Biotechnology companies. Evaxion A/S - Sponsored ADR and NextCure, Inc. are of similar size ($27.2M and $25.4M). Across the 13 metrics below, NextCure, Inc. leads on 7 and Evaxion A/S - Sponsored ADR on 6.
Valuation
Profitability
| Metric | EVAX | NXTC | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 0.00% | 65.16% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | (96.10%) | (195.22%) | (57.72%) |
| Return on assets | (36.20%) | (121.60%) | (49.22%) |
| Return on invested capital | (245.79%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack